As shown in Table 3, immunohistochemistry results suggested numerically differential expression of TIM-3 between the primary and metastatic tumors, with a higher detection rate in the primary than that in the metastasis (53.0% vs 45.4%). Here, HAVCR2 is linked to metastatic neoplasm.